Monday November 9 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Hamilton Laboratories

Below is an extended Hamilton Laboratories research listing. Click here to return to the Hamilton Laboratories main Biocorporate entry.

Recent Publications by Hamilton Laboratories:

Cholesterol-depleting statin drugs protect postmitotically differentiated human neurons against ethanol- and human immunodeficiency virus type 1-induced oxidative stress in vitro.
The majority of human immunodeficiency virus type 1 (HIV-1)-infected...
7th July, 2007
Dorrance H. Hamilton Laboratories, Division of Infectious Diseases, J Virol. 2007 Feb;81(3):1492-501. Epub 2006 Nov 15.
DOI Direct Link
HIV-1 Vpr potently induces programmed cell death in the CNS in vivo.
The human immunodeficiency virus type I (HIV-1) accessory protein Vpr has...
6th April, 2007
The Dorrance H. Hamilton Laboratories, Division of Infectious Diseases and DNA Cell Biol. 2007 Feb;26(2):116-31.
DOI Direct Link
siRNA targeting vaccinia virus double-stranded RNA binding protein [E3L] exerts potent antiviral effects.
The Vaccinia virus gene, E3L, encodes a double-stranded RNA...
1st July, 2006
The Dorrance H. Hamilton Laboratories, Division of Infectious Diseases, Virology. 2006 May 10;348(2):489-97. Epub 2006 Feb 9.
DOI Direct Link
Molecular interactions of human immunodeficiency virus type 1 with primary human oral keratinocytes.
Infection of the oral mucosa of human immunodeficiency virus type 1...
20th August, 2005
The Dorrance H. Hamilton Laboratories, Center for Human Virology and J Virol. 2005 Jul;79(13):8440-53.
DOI Direct Link
Down-modulation of the CXCR4 co-receptor by intracellular expression of a single chain variable fragment (SFv) inhibits HIV-1 entry into primary human brain microvascular endothelial cells and post-mitotic neurons.
Our laboratories previously demonstrated that expression of a single chain...
26th July, 2005
The Dorrance H. Hamilton Laboratories, Center for Human Virology and Brain Res Mol Brain Res. 2005 Apr 27;135(1-2):48-57.
DOI Direct Link
The RNA helicase DDX1 is involved in restricted HIV-1 Rev function in human astrocytes.
Productive infection by human immunodeficiency virus type I (HIV-1) in the...
21st July, 2005
The Dorrance H. Hamilton Laboratories, Center for Human Virology and Virology. 2005 Jun 5;336(2):299-307.
DOI Direct Link
Inhibition of HIV-1 replication by caffeine and caffeine-related methylxanthines.
Human immunodeficiency virus type I (HIV-1) DNA integration is an...
9th June, 2005
The Dorrance H. Hamilton Laboratories, Center for Human Virology and Virology. 2005 May 10;335(2):177-84.
DOI Direct Link
The perlecan heparan sulfate proteoglycan mediates cellular uptake of HIV-1 Tat through a pathway responsible for biological activity.
Cell surface heparan sulfate proteoglycans (HSPGs) mediate internalization...
12th January, 2005
The Dorrance H. Hamilton Laboratories, Division of Infectious Diseases and Virology. 2004 Dec 20;330(2):481-6.
DOI Direct Link
A DEAD box protein facilitates HIV-1 replication as a cellular co-factor of Rev.
HIV-1 Rev escorts unspliced viral mRNAs out of the nucleus of infected...
12th January, 2005
Division of Infectious Diseases and Environmental Medicine, Department of Virology. 2004 Dec 20;330(2):471-80.
DOI Direct Link
Antiviral effects of human immunodeficiency virus type 1-specific small interfering RNAs against targets conserved in select neurotropic viral strains.
RNA interference, a natural biological phenomenon mediated by small...
24th December, 2004
Dorrance H. Hamilton Laboratories, Center for Human Virology and J Virol. 2004 Dec;78(24):13687-96.
DOI Direct Link
HIV-1 Vif versus APOBEC3G: newly appreciated warriors in the ancient battle between virus and host.
The ability of the nonlentiviral retrovirus spleen necrosis virus (SNV) to...
28th July, 2004
Hamilton Laboratories, Center for Human Virology and Biodefense, Division Trends Microbiol. 2004 Apr;12(4):145-8.
Cross-packaging of human immunodeficiency virus type 1 vector RNA by spleen necrosis virus proteins: construction of a new generation of spleen necrosis virus-derived retroviral vectors.
The ability of the nonlentiviral retrovirus spleen necrosis virus (SNV) to...
30th June, 2004
Dorrance H. Hamilton Laboratories, Center for Human Virology and J Virol. 2004 Jun;78(12):6480-8.
DOI Direct Link
HIV-1-mediated apoptosis of neuronal cells: Proximal molecular mechanisms of HIV-1-induced encephalopathy.
The induction of neuronal cell death in vivo has been recognized as a...
23rd June, 2004
Dorrance H. Hamilton Laboratories, Center for Human Virology and Proc Natl Acad Sci U S A. 2004 May 4;101(18):7070-5. Epub 2004 Apr 21.
DOI Direct Link
Recombinant rhabdoviruses as potential vaccines for HIV-1 and other diseases.
The failure to develop vaccines to protect against important infectious...
29th April, 2004
The Dorrance H. Hamilton Laboratories, Center for Human Virology, Curr HIV Res. 2003 Apr;1(2):229-37.
Reduction of serum melatonin levels in HIV-1-infected individuals' parallel disease progression: correlation with serum interleukin-12 levels.
BACKGROUND: During the natural history of human immunodeficiency virus...
13th February, 2004
The Dorrance H. Hamilton Laboratories, Center for Human Virology, Division Infection. 2003 Dec;31(6):379-82.
DOI Direct Link

«Hamilton Laboratories

This page contained an extended Hamilton Laboratories research listing. Click here to return to the Hamilton Laboratories main Biocorporate entry.


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.